{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:56:26Z","timestamp":1791618986390,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T00:00:00Z","timestamp":1667088000000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ygyno.2021.08.033","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T17:37:47Z","timestamp":1631295467000},"page":"294-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort"],"prefix":"10.1016","volume":"163","author":[{"given":"Alli M.","family":"Straubhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin C.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Iasonos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga T.","family":"Filippova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Mario M.","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibraheem O.","family":"Awowole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vance A.","family":"Broach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspreet S.","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ygyno.2021.08.033_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO;2-A","article-title":"Complete excision of pelvic viscera for advanced carcinoma. A one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy","volume":"1","author":"Brunschwig","year":"1948","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.033_bb0010","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.soc.2004.11.011","article-title":"Pelvic exenteration of gynecologic malignancy: indications, and technical and reconstructive considerations","volume":"14","author":"Lambrou","year":"2005","journal-title":"Surg. Oncol. Clin. N. Am."},{"issue":"4","key":"10.1016\/j.ygyno.2021.08.033_bb0015","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1148\/rg.2015140313","article-title":"Role of MR imaging and FDG PET\/CT in selection and follow-up of patients treated with pelvic exenteration for gynecologic malignancies","volume":"35","author":"Lakhman","year":"2015","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.ygyno.2021.08.033_bb0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/ijgc-00009577-200505000-00010","article-title":"Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute","volume":"15","author":"Sharma","year":"2005","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2021.08.033_bb0025","first-page":"73(6)","article-title":"Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix","author":"Shingleton","year":"1989","journal-title":"Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.ygyno.2021.08.033_bb0030","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0002-9378(75)90908-4","article-title":"Exenterative operations: experience with 198 patients","volume":"121","author":"Symmonds","year":"1975","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.033_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ygyno.2005.10.011","article-title":"Total pelvic exenteration: the Albert Einstein College of Medicine\/Montefiore medical center experience (1987 to 2003)","volume":"101","author":"Goldberg","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.ygyno.2021.08.033_bb0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0002-9378(77)90521-X","article-title":"Pelvic exenteration: analysis of 296 patients","volume":"129","author":"Rutledge","year":"1977","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.033_bb0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/IGC.0000000000000612","article-title":"Quality of life in women after pelvic exenteration for gynecological malignancies: a multicentric study","volume":"28","author":"Dessole","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.08.033_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2011.03.003","article-title":"Pelvic exenteration in gynecologic oncology: a single institution study over 20\u00a0years","volume":"122","author":"Benn","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.033_bb0055","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2017.08.014","article-title":"Influence of tumor size on outcomes following pelvic exenteration","volume":"147","author":"Smith","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.08.033_bb0060","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ygyno.2016.10.018","article-title":"Survival after pelvic exenteration for uterine malignancy: a National Cancer Data Base study","volume":"143","author":"Seagle","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.08.033_bb0065","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ygyno.2013.01.017","article-title":"The value of 18F-FDG PET\/CT in recurrent gynecologic malignancies prior to pelvic exenteration","volume":"129","author":"Burger","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.08.033_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2007.03.018","article-title":"A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration","volume":"106","author":"Husain","year":"2007","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2021.08.033_bb0075","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1007\/s00330-013-2875-1","article-title":"Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration","volume":"23","author":"OF","year":"2013","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.033_bb0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0344-0338(11)80700-4","article-title":"The pathologist and the residual tumor (R) classification","volume":"190","author":"Hermanek","year":"1994","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"10.1016\/j.ygyno.2021.08.033_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygyno.2010.11.044","article-title":"Pelvic exenteration in the age of modern chemoradiation","volume":"121","author":"McLean","year":"2011","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.08.033_bb0090","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2014.06.034","article-title":"Overall survival after pelvic exenteration for gynecologic malignancy","volume":"134","author":"Westin","year":"2014","journal-title":"Gynecol. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2021.08.033_bb0095","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ejso.2012.07.002","article-title":"Prognostic factors in pelvic exenteration for gynecological malignancies","volume":"38","author":"Baiocchi","year":"2012","journal-title":"Eur. J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.08.033_bb0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ygyno.2009.03.029","article-title":"Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan","volume":"114","author":"Maggioni","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.08.033_bb0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2019.02.002","article-title":"Performance and outcome of pelvic exenteration for gynecologic malignancies: a population-based study","volume":"153","author":"Matsuo","year":"2019","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821013317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:58:36Z","timestamp":1758772716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821013317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0090825821013317"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.08.033","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}